-
Amyotrophic lateral sclerosis (ALS) is a clinical diagnosis made with a high degree of accuracy (> 90%) by physicians familiar with the disease. No test is diagnostic for ALS.
-
Practice Parameter for Guillain Barré Syndrome; Symposium on Dementia
-
-
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
-
What would happen today if a patient with suspect or probable SARS were admitted to your hospital? To help you prepare for the threat, Thomson American Health Consultants offers the upcoming audio conference: The Resurgence of SARS: Why your hospital may not be as prepared as you think, on Dec. 9, from 2:30-3:30 EST. Let our experts help you answer that and many other critical questions with practical tips and solutions to detect first cases and protect other patients and health care workers.
-
EMTALA: The Essential Guide to Compliance from Thomson American Health Consultants, publisher of Emergency Medicine Reports, explains how the changes to EMTALA will affect emergency departments and off-campus clinics. In-depth articles, at-a-glance tables, and Q-and-As on real-life situations are presented, and key differences between the "old" EMTALA and the new changes are succinctly explained,
-
-
Sleepiness, obesity, hypertension, witnessed apneas, and frequent snoring are prevalent in the general population; demand for diagnostic and treatment services for sleep apnea is likely to skyrocket.
-
More than 90% of individuals studied maintain measurable humoral or T-cell-mediated immunity against vaccinia virus for as long as 75 years after smallpox vaccination.
-
Like patients hospitalized with acute myocardial infarction and total knee replacements, EM of hospitalized patients with CAP reduces overall hospital length of stay and institutional resources without increasing the risk of adverse outcomes.
